nodes	percent_of_prediction	percent_of_DWPC	metapath
Roflumilast—Pancreatitis acute—Dexamethasone—ankylosing spondylitis	0.0265	0.0265	CcSEcCtD
Roflumilast—Pancreatitis acute—Betamethasone—ankylosing spondylitis	0.0265	0.0265	CcSEcCtD
Roflumilast—Pancreatitis acute—Prednisone—ankylosing spondylitis	0.0231	0.0231	CcSEcCtD
Roflumilast—Suicidal ideation—Methylprednisolone—ankylosing spondylitis	0.0192	0.0192	CcSEcCtD
Roflumilast—Suicidal ideation—Betamethasone—ankylosing spondylitis	0.0175	0.0175	CcSEcCtD
Roflumilast—Suicidal ideation—Dexamethasone—ankylosing spondylitis	0.0175	0.0175	CcSEcCtD
Roflumilast—Suicidal ideation—Prednisone—ankylosing spondylitis	0.0152	0.0152	CcSEcCtD
Roflumilast—Endocrine disorder—Prednisone—ankylosing spondylitis	0.0129	0.0129	CcSEcCtD
Roflumilast—Influenza—Triamcinolone—ankylosing spondylitis	0.00847	0.00847	CcSEcCtD
Roflumilast—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.00798	0.00798	CcSEcCtD
Roflumilast—Infestation—Methylprednisolone—ankylosing spondylitis	0.00754	0.00754	CcSEcCtD
Roflumilast—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00754	0.00754	CcSEcCtD
Roflumilast—Renal failure acute—Methotrexate—ankylosing spondylitis	0.00701	0.00701	CcSEcCtD
Roflumilast—Weight decreased—Dexamethasone—ankylosing spondylitis	0.00695	0.00695	CcSEcCtD
Roflumilast—Weight decreased—Betamethasone—ankylosing spondylitis	0.00695	0.00695	CcSEcCtD
Roflumilast—Rhinitis—Triamcinolone—ankylosing spondylitis	0.0068	0.0068	CcSEcCtD
Roflumilast—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00678	0.00678	CcSEcCtD
Roflumilast—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00665	0.00665	CcSEcCtD
Roflumilast—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00628	0.00628	CcSEcCtD
Roflumilast—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00611	0.00611	CcSEcCtD
Roflumilast—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.0061	0.0061	CcSEcCtD
Roflumilast—Weight decreased—Prednisone—ankylosing spondylitis	0.00606	0.00606	CcSEcCtD
Roflumilast—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.00596	0.00596	CcSEcCtD
Roflumilast—Depression—Prednisone—ankylosing spondylitis	0.00595	0.00595	CcSEcCtD
Roflumilast—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00593	0.00593	CcSEcCtD
Roflumilast—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00589	0.00589	CcSEcCtD
Roflumilast—Angioedema—Prednisolone—ankylosing spondylitis	0.00586	0.00586	CcSEcCtD
Roflumilast—Malaise—Prednisolone—ankylosing spondylitis	0.00579	0.00579	CcSEcCtD
Roflumilast—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00578	0.00578	CcSEcCtD
Roflumilast—Vertigo—Prednisolone—ankylosing spondylitis	0.00577	0.00577	CcSEcCtD
Roflumilast—Back pain—Triamcinolone—ankylosing spondylitis	0.00571	0.00571	CcSEcCtD
Roflumilast—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00548	0.00548	CcSEcCtD
Roflumilast—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00546	0.00546	CcSEcCtD
Roflumilast—Discomfort—Prednisolone—ankylosing spondylitis	0.0054	0.0054	CcSEcCtD
Roflumilast—Angioedema—Triamcinolone—ankylosing spondylitis	0.00539	0.00539	CcSEcCtD
Roflumilast—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00538	0.00538	CcSEcCtD
Roflumilast—Malaise—Triamcinolone—ankylosing spondylitis	0.00532	0.00532	CcSEcCtD
Roflumilast—Malaise—Methylprednisolone—ankylosing spondylitis	0.00531	0.00531	CcSEcCtD
Roflumilast—Vertigo—Triamcinolone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Roflumilast—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00529	0.00529	CcSEcCtD
Roflumilast—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00527	0.00527	CcSEcCtD
Roflumilast—Myalgia—Triamcinolone—ankylosing spondylitis	0.00503	0.00503	CcSEcCtD
Roflumilast—Pneumonia—Methotrexate—ankylosing spondylitis	0.00502	0.00502	CcSEcCtD
Roflumilast—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00501	0.00501	CcSEcCtD
Roflumilast—Anxiety—Methylprednisolone—ankylosing spondylitis	0.005	0.005	CcSEcCtD
Roflumilast—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00499	0.00499	CcSEcCtD
Roflumilast—Infestation—Methotrexate—ankylosing spondylitis	0.00499	0.00499	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00498	0.00498	CcSEcCtD
Roflumilast—Depression—Methotrexate—ankylosing spondylitis	0.00497	0.00497	CcSEcCtD
Roflumilast—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00497	0.00497	CcSEcCtD
Roflumilast—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00497	0.00497	CcSEcCtD
Roflumilast—Discomfort—Triamcinolone—ankylosing spondylitis	0.00496	0.00496	CcSEcCtD
Roflumilast—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00495	0.00495	CcSEcCtD
Roflumilast—Angioedema—Betamethasone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Roflumilast—Angioedema—Dexamethasone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Roflumilast—Immune system disorder—Prednisone—ankylosing spondylitis	0.00484	0.00484	CcSEcCtD
Roflumilast—Malaise—Betamethasone—ankylosing spondylitis	0.00483	0.00483	CcSEcCtD
Roflumilast—Malaise—Dexamethasone—ankylosing spondylitis	0.00483	0.00483	CcSEcCtD
Roflumilast—Vertigo—Betamethasone—ankylosing spondylitis	0.00481	0.00481	CcSEcCtD
Roflumilast—Vertigo—Dexamethasone—ankylosing spondylitis	0.00481	0.00481	CcSEcCtD
Roflumilast—Infection—Triamcinolone—ankylosing spondylitis	0.00479	0.00479	CcSEcCtD
Roflumilast—Infection—Methylprednisolone—ankylosing spondylitis	0.00478	0.00478	CcSEcCtD
Roflumilast—Insomnia—Prednisolone—ankylosing spondylitis	0.00474	0.00474	CcSEcCtD
Roflumilast—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00472	0.00472	CcSEcCtD
Roflumilast—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00471	0.00471	CcSEcCtD
Roflumilast—Mental disorder—Prednisone—ankylosing spondylitis	0.00469	0.00469	CcSEcCtD
Roflumilast—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00467	0.00467	CcSEcCtD
Roflumilast—Malnutrition—Prednisone—ankylosing spondylitis	0.00466	0.00466	CcSEcCtD
Roflumilast—Myalgia—Betamethasone—ankylosing spondylitis	0.00456	0.00456	CcSEcCtD
Roflumilast—Myalgia—Dexamethasone—ankylosing spondylitis	0.00456	0.00456	CcSEcCtD
Roflumilast—Anxiety—Betamethasone—ankylosing spondylitis	0.00454	0.00454	CcSEcCtD
Roflumilast—Anxiety—Dexamethasone—ankylosing spondylitis	0.00454	0.00454	CcSEcCtD
Roflumilast—Discomfort—Dexamethasone—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Roflumilast—Discomfort—Betamethasone—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00438	0.00438	CcSEcCtD
Roflumilast—Insomnia—Triamcinolone—ankylosing spondylitis	0.00436	0.00436	CcSEcCtD
Roflumilast—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Roflumilast—Infection—Betamethasone—ankylosing spondylitis	0.00434	0.00434	CcSEcCtD
Roflumilast—Infection—Dexamethasone—ankylosing spondylitis	0.00434	0.00434	CcSEcCtD
Roflumilast—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00433	0.00433	CcSEcCtD
Roflumilast—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00432	0.00432	CcSEcCtD
Roflumilast—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00429	0.00429	CcSEcCtD
Roflumilast—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00429	0.00429	CcSEcCtD
Roflumilast—Angioedema—Prednisone—ankylosing spondylitis	0.00426	0.00426	CcSEcCtD
Roflumilast—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00424	0.00424	CcSEcCtD
Roflumilast—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Roflumilast—Malaise—Prednisone—ankylosing spondylitis	0.00421	0.00421	CcSEcCtD
Roflumilast—Vertigo—Prednisone—ankylosing spondylitis	0.00419	0.00419	CcSEcCtD
Roflumilast—Urticaria—Prednisolone—ankylosing spondylitis	0.00416	0.00416	CcSEcCtD
Roflumilast—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00416	0.00416	CcSEcCtD
Roflumilast—Fatigue—Triamcinolone—ankylosing spondylitis	0.00415	0.00415	CcSEcCtD
Roflumilast—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00414	0.00414	CcSEcCtD
Roflumilast—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00404	0.00404	CcSEcCtD
Roflumilast—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00404	0.00404	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Roflumilast—Myalgia—Prednisone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Roflumilast—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Roflumilast—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00396	0.00396	CcSEcCtD
Roflumilast—Anxiety—Prednisone—ankylosing spondylitis	0.00396	0.00396	CcSEcCtD
Roflumilast—Insomnia—Betamethasone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Roflumilast—Insomnia—Dexamethasone—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Roflumilast—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Roflumilast—Discomfort—Prednisone—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Roflumilast—Mental disorder—Methotrexate—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Roflumilast—Malnutrition—Methotrexate—ankylosing spondylitis	0.0039	0.0039	CcSEcCtD
Roflumilast—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Roflumilast—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Roflumilast—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Roflumilast—Urticaria—Triamcinolone—ankylosing spondylitis	0.00383	0.00383	CcSEcCtD
Roflumilast—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00382	0.00382	CcSEcCtD
Roflumilast—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00382	0.00382	CcSEcCtD
Roflumilast—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.0038	0.0038	CcSEcCtD
Roflumilast—Decreased appetite—Betamethasone—ankylosing spondylitis	0.0038	0.0038	CcSEcCtD
Roflumilast—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.0038	0.0038	CcSEcCtD
Roflumilast—Infection—Prednisone—ankylosing spondylitis	0.00378	0.00378	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Roflumilast—Back pain—Methotrexate—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Roflumilast—Fatigue—Dexamethasone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Roflumilast—Fatigue—Betamethasone—ankylosing spondylitis	0.00377	0.00377	CcSEcCtD
Roflumilast—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00373	0.00373	CcSEcCtD
Roflumilast—Skin disorder—Prednisone—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Roflumilast—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00362	0.00362	CcSEcCtD
Roflumilast—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Roflumilast—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Roflumilast—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Roflumilast—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Roflumilast—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00355	0.00355	CcSEcCtD
Roflumilast—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Roflumilast—Malaise—Methotrexate—ankylosing spondylitis	0.00352	0.00352	CcSEcCtD
Roflumilast—Vertigo—Methotrexate—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Roflumilast—Urticaria—Betamethasone—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Roflumilast—Urticaria—Dexamethasone—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Roflumilast—Dizziness—Prednisolone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Roflumilast—Asthenia—Triamcinolone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Roflumilast—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Roflumilast—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Roflumilast—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Roflumilast—Insomnia—Prednisone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Roflumilast—Dyspepsia—Prednisone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Roflumilast—Myalgia—Methotrexate—ankylosing spondylitis	0.00332	0.00332	CcSEcCtD
Roflumilast—Decreased appetite—Prednisone—ankylosing spondylitis	0.00331	0.00331	CcSEcCtD
Roflumilast—Rash—Prednisolone—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Roflumilast—Dermatitis—Prednisolone—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Roflumilast—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Roflumilast—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00329	0.00329	CcSEcCtD
Roflumilast—Fatigue—Prednisone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Roflumilast—Headache—Prednisolone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Roflumilast—Discomfort—Methotrexate—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Roflumilast—Constipation—Prednisone—ankylosing spondylitis	0.00326	0.00326	CcSEcCtD
Roflumilast—Dizziness—Triamcinolone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Roflumilast—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Roflumilast—Infection—Methotrexate—ankylosing spondylitis	0.00316	0.00316	CcSEcCtD
Roflumilast—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Roflumilast—Asthenia—Betamethasone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Roflumilast—Asthenia—Dexamethasone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Roflumilast—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Roflumilast—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Roflumilast—Nausea—Prednisolone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Roflumilast—Skin disorder—Methotrexate—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Roflumilast—Vomiting—Triamcinolone—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Roflumilast—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Roflumilast—Rash—Triamcinolone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Roflumilast—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00303	0.00303	CcSEcCtD
Roflumilast—Rash—Methylprednisolone—ankylosing spondylitis	0.00303	0.00303	CcSEcCtD
Roflumilast—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00303	0.00303	CcSEcCtD
Roflumilast—Urticaria—Prednisone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Roflumilast—Headache—Triamcinolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Roflumilast—Headache—Methylprednisolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Roflumilast—Abdominal pain—Prednisone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Roflumilast—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Roflumilast—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Roflumilast—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Roflumilast—Dizziness—Dexamethasone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Roflumilast—Dizziness—Betamethasone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Roflumilast—Insomnia—Methotrexate—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Roflumilast—Nausea—Triamcinolone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Roflumilast—Nausea—Methylprednisolone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Roflumilast—Hypersensitivity—Prednisone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Roflumilast—Dyspepsia—Methotrexate—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Roflumilast—Vomiting—Betamethasone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Roflumilast—Vomiting—Dexamethasone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Roflumilast—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Roflumilast—Rash—Betamethasone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Roflumilast—Rash—Dexamethasone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Roflumilast—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Roflumilast—Dermatitis—Betamethasone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Roflumilast—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Roflumilast—Fatigue—Methotrexate—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Roflumilast—Headache—Dexamethasone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Roflumilast—Headache—Betamethasone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Roflumilast—Asthenia—Prednisone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Roflumilast—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00262	0.00262	CcSEcCtD
Roflumilast—Diarrhoea—Prednisone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Roflumilast—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Roflumilast—Nausea—Betamethasone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Roflumilast—Nausea—Dexamethasone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Roflumilast—Urticaria—Methotrexate—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Roflumilast—Dizziness—Prednisone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Roflumilast—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Roflumilast—Vomiting—Prednisone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Roflumilast—Rash—Prednisone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Roflumilast—Dermatitis—Prednisone—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Roflumilast—Headache—Prednisone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Roflumilast—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Roflumilast—Asthenia—Methotrexate—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Roflumilast—Nausea—Prednisone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Roflumilast—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Roflumilast—Dizziness—Methotrexate—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Roflumilast—Vomiting—Methotrexate—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Roflumilast—Rash—Methotrexate—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Roflumilast—Dermatitis—Methotrexate—ankylosing spondylitis	0.002	0.002	CcSEcCtD
Roflumilast—Headache—Methotrexate—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Roflumilast—Nausea—Methotrexate—ankylosing spondylitis	0.00189	0.00189	CcSEcCtD
